Simulations Plus reported financial results for the fourth quarter and fiscal 2025, showcasing revenue changes and key financial metrics.
The company highlighted a decrease in total revenue and software revenue for the fourth quarter, while showing an increase in total revenue for the full fiscal year 2025.
Adjusted EBITDA and adjusted net income comparisons were also provided for both periods.
Revenue Performance
Total revenue decreased by 6% in the fourth quarter and increased by 13% for the full year 2025.
Earnings Metrics
Adjusted diluted EPS guidance for fiscal 2026 ranges from $1.03 to $1.10, with a net loss reported for full year 2025.
Management Outlook
Simulations Plus anticipates low single-digit revenue growth for fiscal 2026, highlighting market conditions and the company's resilience.
- The company's CEO, Shawn O'Connor, emphasized the successful meeting of fiscal 2025 guidance, demonstrating resilience and agility in market dynamics.
- Simulations Plus looks forward to the upcoming Investor Day in January 2026 to present new product visions and AI solutions, aligning with market trends and customer demands.
With validated science at its core and a focus on AI-enabled drug development, Simulations Plus aims to lead the next chapter in the industry.